Dr. Abdul Hai Mansoor
Claim this profileKaiser Permanente Northwest
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
23 reported clinical trials
67 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage III
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Abdul Hai Mansoor is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Abdul Hai Mansoor
Clinical Trial Related2 years of experience running clinical trials · Led 23 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Abdul Hai Mansoor has experience with
- Pembrolizumab
- Rituximab
- Biospecimen Collection
- Selpercatinib
- Carboplatin
- Pemetrexed Disodium
Breakdown of trials Abdul Hai Mansoor has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Abdul Hai Mansoor specialize in?
Abdul Hai Mansoor focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Abdul Hai Mansoor currently recruiting for clinical trials?
Yes, Abdul Hai Mansoor is currently recruiting for 8 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Abdul Hai Mansoor has studied deeply?
Yes, Abdul Hai Mansoor has studied treatments such as Pembrolizumab, Rituximab, Biospecimen Collection.
What is the best way to schedule an appointment with Abdul Hai Mansoor?
Apply for one of the trials that Abdul Hai Mansoor is conducting.
What is the office address of Abdul Hai Mansoor?
The office of Abdul Hai Mansoor is located at: Kaiser Permanente Northwest, Portland, Oregon 97227 United States. This is the address for their practice at the Kaiser Permanente Northwest.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.